CXCL14 is a candidate biomarker for Hedgehog signalling in idiopathic pulmonary fibrosis

Background Idiopathic pulmonary fibrosis (IPF) is associated with aberrant expression of developmental pathways, including Hedgehog (Hh). As Hh signalling contributes to multiple pro-fibrotic processes, Hh inhibition may represent a therapeutic option for IPF. However, no non-invasive biomarkers are available to monitor lung Hh activity. Methods We assessed gene and protein expression in IPF and control lung biopsies, mouse lung, fibroblasts stimulated in vitro with sonic hedgehog (SHh), and plasma in IPF patients versus controls, and cancer patients before and after treatment with vismodegib, a Hh inhibitor. Results Lung tissue from IPF patients exhibited significantly greater expression of Hh-related genes versus controls. The gene most significantly upregulated in both IPF lung biopsies and fibroblasts stimulated in vitro with SHh was CXCL14, which encodes a soluble secreted chemokine whose expression is inhibited in vitro by the addition of vismodegib. CXCL14 expression was induced by SHh overexpression in mouse lung. Circulating CXCL14 protein levels were significantly higher in plasma from IPF patients than controls. In cancer patients, circulating CXCL14 levels were significantly reduced upon vismodegib treatment. Conclusions CXCL14 is a systemic biomarker that could be used to identify IPF patients with increased Hh pathway activity and monitor the pharmacodynamic effects of Hh antagonist therapy in IPF. Trial registration number Post-results, NCT00968981.

[1]  Benjamin L. Allen,et al.  Maintenance of Taste Organs Is Strictly Dependent on Epithelial Hedgehog/GLI Signaling , 2016, PLoS genetics.

[2]  M. Townsend,et al.  Reducing the risk of failure: biomarker-guided trial design , 2016, Nature Reviews Drug Discovery.

[3]  N. Sevenet,et al.  Basal Cell Carcinoma in Gorlin’s Patients: a Matter of Fibroblasts-Led Protumoral Microenvironment? , 2015, PloS one.

[4]  B. Yaspan,et al.  Stratified medicine in inflammatory disorders: From theory to practice. , 2015, Clinical immunology.

[5]  C. Henke,et al.  Reemergence of hedgehog mediates epithelial-mesenchymal crosstalk in pulmonary fibrosis. , 2015, American journal of respiratory cell and molecular biology.

[6]  Zora Modrusan,et al.  Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis , 2014, Thorax.

[7]  A. Mailleux,et al.  Targeting the hedgehog-glioma-associated oncogene homolog pathway inhibits bleomycin-induced lung fibrosis in mice. , 2014, American journal of respiratory cell and molecular biology.

[8]  H. Collard,et al.  Endogenously Expressed IL-13Rα2 Attenuates IL-13–Mediated Responses but Does Not Activate Signaling in Human Lung Fibroblasts , 2014, The Journal of Immunology.

[9]  A. Chang,et al.  Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations , 2014, Current Dermatology Reports.

[10]  T. Hara,et al.  Dimeric peptides of the C‐terminal region of CXCL14 function as CXCL12 inhibitors , 2013, FEBS letters.

[11]  Christopher Miller,et al.  Vismodegib: a hedgehog pathway inhibitor for locally advanced and metastatic basal cell carcinomas. , 2013, Journal of drugs in dermatology : JDD.

[12]  Shandra L. Protzko,et al.  An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. , 2013, American journal of respiratory and critical care medicine.

[13]  Jhingook Kim,et al.  Tumor-stromal interactions with direct cell contacts enhance motility of non-small cell lung cancer cells through the hedgehog signaling pathway. , 2013, Anticancer research.

[14]  R. Crystal,et al.  Smoking-induced CXCL14 expression in the human airway epithelium links chronic obstructive pulmonary disease to lung cancer. , 2013, American journal of respiratory cell and molecular biology.

[15]  T. Hara,et al.  CXCL14 is a natural inhibitor of the CXCL12–CXCR4 signaling axis , 2013, FEBS letters.

[16]  A. Joyner,et al.  Hedgehog signaling in neonatal and adult lung. , 2013, American journal of respiratory cell and molecular biology.

[17]  G. Karaca,et al.  Smoothened is a master regulator of adult liver repair. , 2013, The Journal of clinical investigation.

[18]  F. D’Acquisto,et al.  Tissue-Derived Hedgehog Proteins Modulate Th Differentiation and Disease , 2013, The Journal of Immunology.

[19]  A. Fabre,et al.  The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis. , 2012, The American journal of pathology.

[20]  M. Gaxiola,et al.  Role of Sonic Hedgehog in idiopathic pulmonary fibrosis. , 2012, American journal of physiology. Lung cellular and molecular physiology.

[21]  K. Leslie.  Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis. , 2012, Archives of pathology & laboratory medicine.

[22]  Man Liu,et al.  Neutralization of chemokine CXCL14 (BRAK) expression reduces CCl4 induced liver injury and steatosis in mice. , 2011, European journal of pharmacology.

[23]  J. Berlin,et al.  Pharmacokinetic Dose-Scheduling Study of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors , 2011, Clinical Cancer Research.

[24]  Thomas A. Wynn,et al.  Integrating mechanisms of pulmonary fibrosis , 2011, The Journal of experimental medicine.

[25]  T. Januario,et al.  Pharmacokinetic–Pharmacodynamic Analysis of Vismodegib in Preclinical Models of Mutational and Ligand-Dependent Hedgehog Pathway Activation , 2011, Clinical Cancer Research.

[26]  Stephen Gould,et al.  Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells , 2011, Proceedings of the National Academy of Sciences.

[27]  C. Rudin,et al.  Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors , 2011, Clinical Cancer Research.

[28]  G. Rossi,et al.  The role of histology in idiopathic pulmonary fibrosis: an update. , 2010, Respiratory medicine.

[29]  Yuesheng Li,et al.  Co-ordinated Gene Expression in the Liver and Spleen during Schistosoma japonicum Infection Regulates Cell Migration , 2010, PLoS neglected tropical diseases.

[30]  H. Yonekawa,et al.  CXCL14 Deficiency in Mice Attenuates Obesity and Inhibits Feeding Behavior in a Novel Environment , 2010, PloS one.

[31]  Kenji Suzuki,et al.  Antibody-assisted enhancement of biological activities of CXCL14 in human monocytic leukemia-derived THP-1 cells and high fat diet-induced obese mice. , 2010, Experimental cell research.

[32]  H. Tilg,et al.  Role for hedgehog pathway in regulating growth and function of invariant NKT cells , 2009, European journal of immunology.

[33]  V. Jala,et al.  Activin A induces dendritic cell migration through the polarized release of CXC chemokine ligands 12 and 14. , 2009, Blood.

[34]  M. Frederick,et al.  CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth , 2009, Proceedings of the National Academy of Sciences.

[35]  Min Yu,et al.  Sonic Hedgehog-responsive Genes in the Fetal Prostate* , 2009, Journal of Biological Chemistry.

[36]  W. Seeger,et al.  Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis , 2008, PloS one.

[37]  H. Friess,et al.  CXCL14 expression and potential function in pancreatic cancer. , 2008, Cancer letters.

[38]  H. Yonekawa,et al.  Disruption of CXC Motif Chemokine Ligand-14 in Mice Ameliorates Obesity-induced Insulin Resistance* , 2007, Journal of Biological Chemistry.

[39]  R. Schwabe,et al.  Gene expression profiles during hepatic stellate cell activation in culture and in vivo. , 2007, Gastroenterology.

[40]  Lee L. Rubin,et al.  Targeting the Hedgehog pathway in cancer , 2006, Nature Reviews Drug Discovery.

[41]  U. V. von Andrian,et al.  Murine CXCL14 Is Dispensable for Dendritic Cell Function and Localization within Peripheral Tissues , 2006, Molecular and Cellular Biology.

[42]  R. Hromas,et al.  The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: implications for the downregulation of CXCL14 in malignancy. , 2006, Experimental hematology.

[43]  D. Roberts,et al.  Differential epithelial expression of SHH and FOXF1 in usual and nonspecific interstitial pneumonia. , 2006, Experimental and molecular pathology.

[44]  R. Ferris,et al.  Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo. , 2006, The Journal of Immunology.

[45]  W. Isaacs,et al.  Modulation of CXCL14 (BRAK) expression in prostate cancer , 2005, The Prostate.

[46]  A. El‐Naggar,et al.  BRAK/CXCL14 Is a Potent Inhibitor of Angiogenesis and a Chemotactic Factor for Immature Dendritic Cells , 2004, Cancer Research.

[47]  V. Poletti,et al.  Aberrant Wnt/ (cid:1) -Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis , 2003 .

[48]  C. Haslett,et al.  Expression of the developmental Sonic hedgehog (Shh) signalling pathway is up‐regulated in chronic lung fibrosis and the Shh receptor patched 1 is present in circulating T lymphocytes , 2003, The Journal of pathology.

[49]  A. McMahon,et al.  Sonic hedgehog regulates branching morphogenesis in the mammalian lung , 1998, Current Biology.

[50]  A. Joyner,et al.  Sonic hedgehog signaling in the lung. From development to disease. , 2015, American journal of respiratory cell and molecular biology.

[51]  S. Rosselot.  Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[52]  M. Lauth,et al.  Hedgehog signaling and pancreatic tumor development. , 2011, Advances in cancer research.

[53]  D. Warburton,et al.  The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? , 2008, The international journal of biochemistry & cell biology.

[54]  V. Poletti,et al.  Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. , 2003, The American journal of pathology.

[55]  B. Hogan,et al.  Involvement of Sonic hedgehog (Shh) in mouse embryonic lung growth and morphogenesis. , 1997, Development.